TAR-200, a small drug-releasing implant, wiped out tumors in most patients with high-risk bladder cancer. Its slow, ...

The US Food and Drug Administration has approved Johnson & Johnson’s drug delivery system for a type of bladder cancer, offering a potential surgery-free option for patients. The drug release system, ...

An innovative new treatment option for bladder cancer, recently approved by the U.S. Food and Drug Administration, has been performed for the first time in Maryland.

The trial showed that 63% of patients achieved a complete response (CR) at any time after receiving detalimogene coraplasmid.

The press conference was held at 11 a.m. Monday, which you can watch below. BOULDER, Colo. (KRDO) -- University of Colorado (CU) head coach Deion Sanders holds a press conference to discuss ...